Country: Romania
Language: English
Source: HMA (Heads of Medicines Agencies)
mycoplasma hyopneumoniae 1 RP
Bioveta
QI09AB13
Emulsion for injection
Mycoplasma
Pigs Other
2012-12-21
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT BIOSUIS M.HYO, emulsion for injection for pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One vaccine dose (2 ml of vaccine) contains: ACTIVE SUBSTANCES: Inactivated_ Mycoplasma hyopneumoniae_ RP ≥ 1* *RP = Relative potency (ELISA test) as compared with the reference serum obtained after vaccination of mice with a vaccine batch that has successfully passed the challenge test on the target species. . ADJUVANT: Montanide ISA 35 VG 0.2 ml EXCIPIENTS: Formaldehyde solution 35% max. 2 mg Thiomersal 0.17 – 0.23 mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Emulsion for injection. Milky liquid of yellowish-white to light pink colour without sediment or with small amount of sediment dispersing after shaking. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs (fattening pigs) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For active immunization of fattening pigs to mitigate the effects of infection with _Mycoplasma _ _hyopneumoniae_ - a causative agent of enzootic pneumonia in pigs. The onset of immunity has been demonstrated in vaccinated piglets 14 days after vaccination or revaccination if 2 doses were applied. Vaccine ensures duration of immunity during fattening. 4.3 Read the complete document